azides has been researched along with levetiracetam in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatelain, P; Fuks, B; Gillard, M; Massingham, R; Michel, P; Vertongen, P | 1 |
| Chatelain, P; Fuks, B; Gillard, M; Lambeng, N; Vertongen, P | 1 |
| Chatelain, P; Fuks, B; Gillard, M | 1 |
3 other study(ies) available for azides and levetiracetam
| Article | Year |
|---|---|
Binding characteristics of [3H]ucb 30889 to levetiracetam binding sites in rat brain.
Topics: Animals; Anticonvulsants; Azides; Binding, Competitive; Brain; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Levetiracetam; Male; Piracetam; Pyrrolidines; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tritium | 2003 |
Characterization of [(3)H]ucb 30889 binding to synaptic vesicle protein 2A in the rat spinal cord.
Topics: Animals; Anticonvulsants; Azides; Binding Sites; Binding, Competitive; Dose-Response Relationship, Drug; Kinetics; Levetiracetam; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Pyrrolidines; Rats; Rats, Sprague-Dawley; Spinal Cord; Synaptic Vesicles | 2005 |
Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.
Topics: Animals; Azides; Binding Sites; Binding, Competitive; Brain; Cerebellum; Cerebral Cortex; CHO Cells; Cricetinae; Cricetulus; Female; Gene Expression; Hippocampus; Humans; Kinetics; Levetiracetam; Male; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Pyrrolidines; Recombinant Proteins; Tritium | 2006 |